RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
VWENX
Price
$82.35
Change
+$0.21 (+0.26%)
Updated
Oct 17 closing price
Net Assets
119.52B
Interact to see
Advertisement

RLBCX vs VWENX

Header iconRLBCX vs VWENX Comparison
Open Charts RLBCX vs VWENXBanner chart's image
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
Vanguard Wellington™ Admiral™
Price$82.35
Change+$0.21 (+0.26%)
VolumeN/A
Net Assets119.52B
RLBCX vs VWENX Comparison Chart in %
View a ticker or compare two or three
VS
RLBCX vs. VWENX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBCX is a Buy and VWENX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. VWENX (120B). VWENX pays higher dividends than RLBCX: VWENX (1.97) vs RLBCX (1.49). RLBCX was incepted earlier than VWENX: RLBCX (23 years) vs VWENX (24 years). RLBCX (0.89) is less costly to investors than VWENX (0.17). VWENX is a more actively managed with annual turnover of: 61.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than VWENX: RLBCX (250) vs VWENX (50000). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. VWENX (3.60). RLBCX return over 5 years is better than : 40.24 vs. VWENX (12.05).
RLBCXVWENXRLBCX / VWENX
Total Expense Ratio0.890.17524%
Annual Report Gross Expense Ratio0.890.17524%
Fund Existence23 years24 years-
Gain YTD14.36412.205118%
Front LoadN/AN/A-
Min. Initial Investment250500001%
Min. Initial Investment IRAN/AN/A-
Net Assets265B120B221%
Annual Yield % from dividends1.491.9776%
Returns for 1 year8.343.60232%
Returns for 3 years49.2627.11182%
Returns for 5 years40.2412.05334%
Returns for 10 years72.1837.32193%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN24.211.20
+5.22%
Viridian Therapeutics
ACI19.740.51
+2.65%
Albertsons Companies
PRFX1.24N/A
-0.40%
PainReform Ltd
BOC13.76-0.10
-0.72%
Boston Omaha Corp
ASRT0.80-0.02
-2.90%
Assertio Holdings